No Data
RBC Lowers Price Target on Verrica Pharmaceuticals to $11 From $13, Keeps Outperform, Speculative Risk
12 Health Care Stocks Moving In Thursday's Intraday Session
This Tractor Supply Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Verrica Pharmaceuticals Price Target Maintained With a $12.00/Share by Needham
Express News | Verrica Pharmaceuticals Shares Are Trading Lower After the Company Announced a Structuring to Reduce Costs and Expand Access to YCANTH for the Treatment of Molluscum Contagiosum. Also, Brookline Capital Downgraded the Stock From Buy to Hold
Verrica Pharmaceuticals Shares Are Trading Lower After the Company Announced a Structuring to Reduce Costs and Expand Access to YCANTH for the Treatment of Molluscum Contagiosum. Also, Brookline Capital Downgraded the Stock From Buy to Hold.